Multi-targeted prevention of cancer by sulforaphane

Cancer Letters

Volumn 269, Issue 2, 2008, Pages 291-304

  Clarke, John D ^a   Dashwood, Roderick H ^a,b   Ho, Emily ^a,b  

^a OREGON STATE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

Chemoprevention; Colorectal cancer; Prostate cancer; Sulforaphane

Indexed keywords

CARCINOGEN; HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; SULFORAPHANE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BIOAVAILABILITY; BROCCOLI; CANCER PREVENTION; CANCER RISK; CELL CULTURE; CELL CYCLE ARREST; CHEMOPROPHYLAXIS; COLORECTAL CANCER; ENZYME INDUCTION; ENZYME INHIBITION; HUMAN; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; TUMOR XENOGRAFT; VEGETABLE;

ANIMALIA; BRASSICA OLERACEA VAR. BOTRYTIS; BRASSICA OLERACEA VAR. CAPITATA; BRASSICA OLERACEA VAR. GEMMIFERA; BRASSICA OLERACEA VAR. ITALICA;

EID: 51349088974     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.04.018     Document Type: Review

References (68)

1. Joseph M.A., Moysich K.B., Freudenheim J.L., Shields P.G., Bowman E.D., Zhang Y., Marshall J.R., and Ambrosone C.B. Cruciferous vegetables, genetic polymorphisms in glutathione s-transferases m1 and t1, and prostate cancer risk. Nutr. Cancer 50 (2004) 206-213
2. Lin H.J., Probst-Hensch N.M., Louie A.D., Kau I.H., Witte J.S., Ingles S.A., Frankl H.D., Lee E.R., and Haile R.W. Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol. Biomarkers Prev. 7 (1998) 647-652
3. Mosbah A.F.B., Kushad M., Kurilich A.C., Juvik J.A., Klein B.P., Wallig M.A., and Jeffrey E.H. Variation of glucosinolates in vegetable crops of Brassica oleracea. J. Agric. Food Chem. 47 (1999) 1541-1548
4. Mithen R. Glucosinolates - biochemistry, genetics and biological activity. Plant Growth Regul. 34 (2001) 91-103
5. Zhang Y., Talalay P., Cho C.G., and Posner G.H. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc. Natl. Acad. Sci. USA 89 (1992) 2399-2403
6. Higdon J.V., Delage B., Williams D.E., and Dashwood R.H. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol. Res. 55 (2007) 224-236
7. Juge N., Mithen R.F., and Traka M. Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol. Life Sci. 64 (2007) 1105-1127
8. Zhang Y., Talalay P., Cho C.G., and Posner G.H. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc. Natl. Acad. Sci. USA 89 (1992) 2399-2403
9. Maheo K., Morel F., Langouet S., Kramer H., Le Ferrec E., Ketterer B., and Guillouzo A. Inhibition of cytochromes p-450 and induction of glutathione s-transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res. 57 (1997) 3649-3652
10. Myzak M.C., and Dashwood R.H. Chemoprotection by sulforaphane: keep one eye beyond keap1. Cancer Lett. 233 (2006) 208-218
11. Brooks J.D., Paton V.G., and Vidanes G. Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 949-954
12. Keck A.S., Qiao Q., and Jeffery E.H. Food matrix effects on bioactivity of broccoli-derived sulforaphane in liver and colon of f344 rats. J. Agric. Food Chem. 51 (2003) 3320-3327
13. Jones S.B., and Brooks J.D. Modest induction of phase 2 enzyme activity in the f-344 rat prostate. BMC Cancer 6 (2006) 62
14. Petri N., Tannergren C., Holst B., Mellon F.A., Bao Y., Plumb G.W., Bacon J., O'Leary K.A., Kroon P.A., Knutson L., Forsell P., Eriksson T., Lennernas H., and Williamson G. Absorption/metabolism of sulforaphane and quercetin, and regulation of phase ii enzymes, in human jejunum in vivo. Drug Metab. Dispos. 31 (2003) 805-813
15. Thimmulappa R.K., Mai K.H., Srisuma S., Kensler T.W., Yamamoto M., and Biswal S. Identification of nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 62 (2002) 5196-5203
16. Hu R., Xu C., Shen G., Jain M.R., Khor T.O., Gopalkrishnan A., Lin W., Reddy B., Chan J.Y., and Kong A.N. Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of c57bl/6j mice and c57bl/6j/nrf2 (-/-) mice. Cancer Lett. 243 (2006) 170-192
17. McWalter G.K., Higgins L.G., McLellan L.I., Henderson C.J., Song L., Thornalley P.J., Itoh K., Yamamoto M., and Hayes J.D. Transcription factor nrf2 is essential for induction of nad(p)h:quinone oxidoreductase 1, glutathione s-transferases, and glutamate cysteine ligase by broccoli seeds and isothiocyanates. J. Nutr. 134 (2004) 3499S-3506S
18. Singh S.V., Herman-Antosiewicz A., Singh A.V., Lew K.L., Srivastava S.K., Kamath R., Brown K.D., Zhang L., and Baskaran R. Sulforaphane-induced g2/m phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25c. J. Biol. Chem. 279 (2004) 25813-25822
19. Herman-Antosiewicz A., Xiao H., Lew K.L., and Singh S.V. Induction of p21 protein protects against sulforaphane-induced mitotic arrest in lncap human prostate cancer cell line. Mol. Cancer Ther. 6 (2007) 1673-1681
20. Cho S.D., Li G., Hu H., Jiang C., Kang K.S., Lee Y.S., Kim S.H., and Lu J. Involvement of c-jun N-terminal kinase in g2/m arrest and caspase-mediated apoptosis induced by sulforaphane in du145 prostate cancer cells. Nutr. Cancer 52 (2005) 213-224
21. Parnaud G., Li P., Cassar G., Rouimi P., Tulliez J., Combaret L., and Gamet-Payrastre L. Mechanism of sulforaphane-induced cell cycle arrest and apoptosis in human colon cancer cells. Nutr. Cancer 48 (2004) 198-206
22. Gamet-Payrastre L., Li P., Lumeau S., Cassar G., Dupont M.-A., Chevolleau S., Gasc N., Tulliez J., and Terce F. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in ht29 human colon cancer cells. Cancer Res. 60 (2000) 1426-1433
23. Shen G., Xu C., Chen C., Hebbar V., and Kong A.-N. P53-independent g1 cell cycle arrest of human colon carcinoma cells ht-29 by sulforaphane is associated with induction of p21cip1 and inhibition of expression of cyclin d1. Cancer Chemother. Pharmacol. 57 (2006) 317-327
24. Chiao J.W., Chung F.L., Kancherla R., Ahmed T., Mittelman A., and Conaway C.C. Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int. J. Oncol. 20 (2002) 631-636
25. Wang L., Liu D., Ahmed T., Chung F.L., Conaway C., and Chiao J.W. Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Int. J. Oncol. 24 (2004) 187-192
26. Jakubikova J., Sedlak J., Mithen R., and Bao Y. Role of pi3k/akt and mek/erk signaling pathways in sulforaphane- and erucin-induced phase ii enzymes and mrp2 transcription, g2/m arrest and cell death in caco-2 cells. Biochem. Pharmacol. 69 (2005) 1543-1552
27. Pappa G., Bartsch H., and Gerhäuser C. Biphasic modulation of cell proliferation by sulforaphane at physiologically relevant exposure times in a human colon cancer cell line. Mol. Nutr. Food Res. 51 (2007) 977-984
28. Traka M., Gasper A.V., Smith J.A., Hawkey C.J., Bao Y., and Mithen R.F. Transcriptome analysis of human colon caco-2 cells exposed to sulforaphane. J. Nutr. 135 (2005) 1865-1872
29. Myzak M.C., Hardin K., Wang R., Dashwood R.H., and Ho E. Sulforaphane inhibits histone deacetylase activity in bph-1, lncap and pc-3 prostate epithelial cells. Carcinogenesis 27 (2006) 811-819
30. Pappa G., Lichtenberg M., Iori R., Barillari J., Bartsch H., and Gerhauser C. Comparison of growth inhibition profiles and mechanisms of apoptosis induction in human colon cancer cell lines by isothiocyanates and indoles from brassicaceae. Mutat. Res. 599 (2006) 76-87
31. Singh A.V., Xiao D., Lew K.L., Dhir R., and Singh S.V. Sulforaphane induces caspase-mediated apoptosis in cultured pc-3 human prostate cancer cells and retards growth of pc-3 xenografts in vivo. Carcinogenesis 25 (2004) 83-90
32. Halkidou K., Gaughan L., Cook S., Leung H.Y., Neal D.E., and Robson C.N. Upregulation and nuclear recruitment of hdac1 in hormone refractory prostate cancer. Prostate 59 (2004) 177-189
33. Huffman D.M., Grizzle W.E., Bamman M.M., Kim J.-s., Eltoum I.A., Elgavish A., and Nagy T.R. Sirt1 is significantly elevated in mouse and human prostate cancer. Cancer Res. 67 (2007) 6612-6618
34. Seligson D.B., Horvath S., Shi T., Yu H., Tze S., Grunstein M., and Kurdistani S.K. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 435 (2005) 1262-1266
35. Zhu P., Martin E., Mengwasser J., Schlag P., Janssen K.-P., and Gottlicher M. Induction of hdac2 expression upon loss of apc in colorectal tumorigenesis. Cancer Cell 5 (2004) 455-463
36. Johnstone R.W. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat. Rev. Drug Discov. 1 (2002) 287-299
37. Myzak M.C., Karplus P.A., Chung F.L., and Dashwood R.H. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res. 64 (2004) 5767-5774
38. Dashwood R.H., and Ho E. Dietary histone deacetylase inhibitors: from cells to mice to man. Semin. Cancer Biol. 17 (2007) 363-369
39. Myzak M.C., Dashwood W.M., Orner G.A., Ho E., and Dashwood R.H. Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in apc-minus mice. FASEB J. 20 (2006) 506-508
40. Jeong W.S., Kim I.W., Hu R., and Kong A.N. Modulation of ap-1 by natural chemopreventive compounds in human colon ht-29 cancer cell line. Pharm. Res. 21 (2004) 649-660
41. Xu C., Shen G., Yuan X., Kim J.H., Gopalkrishnan A., Keum Y.S., Nair S., and Kong A.N. Erk and jnk signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer pc-3 cells. Carcinogenesis 27 (2006) 437-445
42. Keum Y.-S., Yu S., Chang P.P.-J., Yuan X., Kim J.-H., Xu C., Han J., Agarwal A., and Kong A.-N.T. Mechanism of action of sulforaphane: inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma hepg2 cells. Cancer Res. 66 (2006) 8804-8813
43. Rayet B., and Gelinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18 (1999) 6938-6947
44. Baldwin A.S. Control of oncogenesis and cancer therapy resistance by the transcription factor nf-{{kappa}}b. J. Clin. Invest. 107 (2001) 241-246
45. Choi S., Lew K.L., Xiao H., Herman-Antosiewicz A., Xiao D., Brown C.K., and Singh S.V. d,l-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and apaf-1. Carcinogenesis 28 (2007) 151-162
46. Xu C., Shen G., Chen C., Gelinas C., and Kong A.N. Suppression of nf-kappab and nf-kappab-regulated gene expression by sulforaphane and peitc through ikappabalpha, ikk pathway in human prostate cancer pc-3 cells. Oncogene 24 (2005) 4486-4495
47. Jeong W.S., Kim I.W., Hu R., and Kong A.N. Modulatory properties of various natural chemopreventive agents on the activation of nf-kappab signaling pathway. Pharm. Res. 21 (2004) 661-670
48. Singh S.V., Srivastava S.K., Choi S., Lew K.L., Antosiewicz J., Xiao D., Zeng Y., Watkins S.C., Johnson C.S., Trump D.L., Lee Y.J., Xiao H., and Herman-Antosiewicz A. Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. J. Biol. Chem. 280 (2005) 19911-19924
49. Herman-Antosiewicz A., Johnson D.E., and Singh S.V. Sulforaphane causes autophagy to inhibit release of cytochrome c and apoptosis in human prostate cancer cells. Cancer Res. 66 (2006) 5828-5835
50. Bones A.M., and Rossiter J.T. The myrosinase-glucosinolate system, its organisation and biochemistry. Physiologia Plantarum 97 (1996) 194-208
51. Kassahun K., Davis M., Hu P., Martin B., and Baillie T. Biotransformation of the naturally occurring isothiocyanate sulforaphane in the rat: identification of phase i metabolites and glutathione conjugates. Chem. Res. Toxicol. 10 (1997) 1228-1233
52. Conaway C.C., Getahun S.M., Liebes L.L., Pusateri D.J., Topham D.K.W., Botero-Omary M., and Chung F.-L. Disposition of glucosinolates and sulforaphane in humans after ingestion of steamed and fresh broccoli. Nutr. Cancer 38 (2000) 168-178
53. Shapiro T.A., Fahey J.W., Wade K.L., Stephenson K.K., and Talalay P. Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables. Cancer Epidemiol. Biomarkers Prev. 7 (1998) 1091-1100
54. Bheemreddy R.M., and Jeffery E.H. The metabolic fate of purified glucoraphanin in f344 rats. J. Agric. Food Chem. 55 (2007) 2861-2866
55. Shapiro T.A., Fahey J.W., Wade K.L., Stephenson K.K., and Talalay P. Chemoprotective glucosinolates and isothiocyanates of broccoli sprouts: metabolism and excretion in humans. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 501-508
56. Seow A., Vainio H., and Yu M.C. Effect of glutathione-s-transferase polymorphisms on the cancer preventive potential of isothiocyanates: an epidemiological perspective. Mutat. Res. 592 (2005) 58-67
57. Lampe J.W., and Peterson S. Brassica, biotransformation and cancer risk: genetic polymorphisms alter the preventive effects of cruciferous vegetables. J. Nutr. 132 (2002) 2991-2994
58. Seow A., Shi C.Y., Chung F.L., Jiao D., Hankin J.H., Lee H.P., Coetzee G.A., and Yu M.C. Urinary total isothiocyanate (itc) in a population-based sample of middle-aged and older hinese in Singapore: relationship with dietary total itc and glutathione s-transferase m1/t1/p1 genotypes. Cancer Epidemiol. Biomarkers Prev. 7 (1998) 775-781
59. Seow A., Yuan J.M., Sun C.L., Van Den Berg D., Lee H.P., and Yu M.C. Dietary isothiocyanates glutathione s-transferase polymorphisms and colorectal cancer risk in the singapore chinese health study. Carcinogenesis 23 (2002) 2055-2061
60. Gasper A.V., Al-Janobi A., Smith J.A., Bacon J.R., Fortun P., Atherton C., Taylor M.A., Hawkey C.J., Barrett D.A., and Mithen R.F. Glutathione s-transferase m1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli. Am. J. Clin. Nutr. 82 (2005) 1283-1291
61. Hu R., Hebbar V., Kim B.R., Chen C., Winnik B., Buckley B., Soteropoulos P., Tolias P., Hart R.P., and Kong A.N. In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat. J. Pharmacol. Exp. Ther. 310 (2004) 263-271
62. Ye L., Dinkova-Kostova A.T., Wade K.L., Zhang Y., Shapiro T.A., and Talalay P. Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans. Clin Chim. Acta 316 (2002) 43-53
63. Cornblatt B.S., Ye L., Dinkova-Kostova A.T., Erb M., Fahey J.W., Singh N.K., Chen M.-S.A., Stierer T., Garrett-Mayer E., Argani P., Davidson N.E., Talalay P., Kensler T.W., and Visvanathan K. Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis 28 (2007) 1485-1490
64. Hu R., Khor T.O., Shen G., Jeong W.S., Hebbar V., Chen C., Xu C., Reddy B., Chada K., and Kong A.N. Cancer chemoprevention of intestinal polyposis in apcmin/+ mice by sulforaphane, a natural product derived from cruciferous vegetable. Carcinogenesis 27 (2006) 2038-2046
65. Chung F.L., Conaway C.C., Rao C.V., and Reddy B.S. Chemoprevention of colonic aberrant crypt foci in fischer rats by sulforaphane and phenethyl isothiocyanate. Carcinogenesis 21 (2000) 2287-2291
66. Myzak M.C., Tong P., Dashwood W.M., Dashwood R.H., and Ho E. Sulforaphane retards the growth of human pc-3 xenografts and inhibits hdac activity in human subjects. Exp. Biol. Med. (Maywood) 232 (2007) 227-234
67. Shapiro T.A., Fahey J.W., Dinkova-Kostova A.T., Holtzclaw W.D., Stephenson K.K., Wade K.L., Ye L., and Talalay P. Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: a clinical phase i study. Nutr. Cancer 55 (2006) 53-62
68. Kensler T.W., Chen J.-G., Egner P.A., Fahey J.W., Jacobson L.P., Stephenson K.K., Ye L., Coady J.L., Wang J.-B., Wu Y., Sun Y., Zhang Q.-N., Zhang B.-C., Zhu Y.-R., Qian G.-S., Carmella S.G., Hecht S.S., Benning L., Gange S.J., Groopman J.D., and Talalay P. Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in he zuo township, Qidong, people's republic of china. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 2605-2613